Combined-Shape-blue
Microbiome
First

PATHWAY TO
SUSTAINABLE
HEALTHCARE

Virtual Summit
May 17-19, 2022
Register
"Noncommunicable diseases (NCDs) account for 71% of all deaths globally, and the economic burden of these diseases is alarmingly unsustainable." 

World Health Organization
To watch the sessions, 

Click here to go to the Schedule page, 

then click the speaker names to see their session
 
Interview with Rodney Dietert, PhD, Cornell University Professor Emeritus, Author of The Human Superorganism

Can Microbiome Science Bring about a Sea Change in Medical Care?

A growing number of experts envision fundamental changes in the way doctors diagnose and treat disease, potentially ushering in a new era of sustainability in healthcare.

The World Asthma Foundation introduces the Microbiome First - Pathway to Sustainable Healthcare initiative and invites healthcare professionals, non-communicable disease community leaders, and stakeholders to participate in the inaugural Microbiome First Summit, a pathway to sustainable healthcare.
Summit Details:
The goal of sustainable healthcare is to improve quality of life at reduced cost by addressing the microbiome first, as recent research shows that all of these non-communicable diseases have a relationship to the microbiome.

The three-day virtual summit, May 17-19, 2022, brings together thought leaders to present Microbiome First strategies, beyond the soundbites and buzzwords, that is designed to provide thoughtful and meaningful discussions.

Noncommunicable diseases and conditions or NCDs are the number 1 world-wide cause of death. Most of the more than 150 chronic disorders fall into three major categories (allergic, autoimmune or inflammatory). They are also known by the systems they affect:
Respiratory (asthma, COPD)
Cardiovascular (atherosclerosis, stroke)
Metabolic (diabetes, obesity)
Neurologic (depression, autism, Alzheimer’s, Parkinson’s)
Gastrointestinal (IBD, celiac, crohn's)
Urogenital (PCOS, chronic kidney disease)
Dermal (psoriasis)
Endocrine (Addison’s), and various cancers
Systemic NCDs also exist (e.g., lupus and frailty). Both the risk of and persistence of NCDs are significantly influenced by the human microbiome.

The Microbiome First - Pathway to Sustainable Healthcare is a suggested 21st century healthcare paradigm that prioritizes the entire human, the human superorganism, beginning with the microbiome.
What You'll Learn:
The Microbiome First - Pathway to Sustainable Healthcare summit panel discussion aims to kickstart a 21st century healthcare paradigm that prioritizes:
Focus on the human microbiome that could facilitate the move toward sustainable healthcare
How certain keystone bacteria and critical windows of development show that changes in even a few microbiota-prioritized medical decisions could make a significant difference in health across the life course
Barriers and challenges
Tracks:
The three-day event features separate tracks with multiple sessions per track.

Individual tracks will cover relevant issues including:
Societal cost of NCDs including the allergic,autoimmune or inflammatory process
The impact and burden of NCDs to those that suffer and costs to your pocket book and the global economy
Environmental impacts to overall health and the Microbiome
Critical windows
Current global clinical trials
Microbiome management
Microbiome success stories
Register:
Everyone is invited and it's free to participate. Microbiome First - Pathway to Sustainable Healthcare Virtual Summit taking place May 17-19, 2022.

Keynote

The cost of Healthcare increases each year, but overall health of the general population does not improve. Non-communicable diseases kill millions of people but there are very few cures. This summit aims to change the way NCDs are managed.

Rodney
Dietert, PhD

"Big Picture View of Our Tiny Microbes"
Cornell University Professor Emeritus
Ithaca, NY, USA
Author of The Human Superorganism.



Learn More

SpeakerS

The cost of Healthcare increases each year, but overall health of the general population does not improve. Non-communicable diseases kill millions of people but there are very few cures. This summit aims to change the way NCDs are managed.

World Asthma Foundation

"Impact and burden of NCDs"
WAF’s mission is to empower the World Asthma community through education, collaboration, and advocacy.
Learn More

Marie-Claire Arrieta, PhD

"The early-life mycobiome in immune and metabolic development"
Associate Professor, departments of Physiology, Pharmacology, and Pediatrics, University of Calgary.
Calgary, AB, CANADA

Learn More

Jaeyun Sung, PhD

"Assessing Health through Gut Microbiome Profiling"
Assistant Professor, Microbiome Program, Center for Individualized Medicine, Mayo Clinic.
Rochester, MN, USA



Learn More

Katrine L. Whiteson, PhD

"High-Fiber, Whole-Food Dietary Intervention Alters the Human Gut Microbiome but Not Fecal Short-Chain Fatty Acids"
Associate Professor, Molecular Biology and Biochemistry School of Biological Sciences
Associate Director, UCI Microbiome Initiative.
Irvine, CA, USA 

Learn More

Lisa Aziz-Zadeh, PhD

"Brain-Gut-Microbiome System: Pathways and Implications for Autism Spectrum Disorder"
Expert on the brain’s role in creativity, language and empathy.
Associate Professor in the USC Chan Division of Occupational Science and Occupational Therapy.
Los Angeles, CA, USA

Learn More

Martin Kriegel, MD, PhD

"Dietary Resistant Starch Effects on Gut Pathobiont Translocation and Systemic Autoimmunity"
Chief of Rheumatology and Clinical Immunology at University Hospital of Münster.
GERMANY
Adjunct Associate Professor in Immunobiology at Yale School of Medicine.

Learn More

Justin Sonnenburg, PhD

"Gut-microbiota-targeted diets modulate human immune status"
Senior research scientist and Associate Professor in the Department of Microbiology and Immunology at the Stanford University School of Medicine.
Palo Alto, CA, USA
Learn More

Emma Hamilton-Williams, PhD

"Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation"
Associate Professor, Principal Research Fellow The University of Queensland Diamantina Institute
Faculty of Medicine
The University of Queensland
Translational Research Institute.
Woolloongabba, QLD, AUSTRALIA
Learn More

Andres Cubillos-Ruiz, PhD

"Protecting the gut microbiota from antibiotics with engineered live biotherapeutics"
Scientist, Wyss Institute of Harvard University and Institute of Medical Engineering and Science of Massachusetts Institute of Technology (MIT)
Boston, MA, USA


Learn More.

Emeran A Mayer, MD

"The Gut–Brain Axis and the Microbiome: Mechanisms and Clinical Implications"
Gastroenterologist, Neuroscientist,  Distinguished Research Professor
Department of Medicine, UCLA David Geffen School of Medicine
Executive Director, G. Oppenheimer Center for Neurobiology of Stress and Resilience at UCLA
Founding Director, UCLA Brain Gut Microbiome Center.
Los Angeles, CA, USA
Learn More

Benoit Chassaing, PhD

"Ubiquitous food additive and microbiota and intestinal environment"
Principal Investigator, Chassaing Lab
Associate professor, French National Institute of Health and Medical Research.
Paris, FRANCE



Learn More

Lieke van den Elsen, PhD

"Gut Microbiota by Breastfeeding: The Gateway to Allergy Prevention"
Research Fellow, The University of Western Australia
Honorary Research Associate, Telethon Kids Institute.
Perth, WA, AUSTRALIA




Learn More

Patricia Macchiaverni, PhD

"House dust mite shedding in human milk: a neglected cause of allergy susceptibility"
Clinical and translational researcher
Research Fellow, The University of Western Australia
Honorary Research Associate, Telethon Kids Institute.
Perth, WA, AUSTRALIA



Learn More

Sei Won Lee, MD, PhD

"The therapeutic application of gut-lung axis in chronic respiratory disease"
Associate Professor
College of Medicine, University of Ulsan
Department of Pulmonary and Critical Care, Asan Medical Center
Seoul, KOREA



Learn More

Paul Turner, PhD

"New Yale Center to Advance Phage Research, Understanding, Treatments, Training, Education"
Rachel Carson Professor of Ecology and Evolutionary Biology, Yale University
Microbiology faculty member, Yale School of Medicine.
New Haven, CT, USA



Learn More

Claudia S. Miller, MD

"Toxicant-Induced Loss of Tolerance for Chemicals, Foods, and Drugs: A Global Phenomenon"
Emeritus Professor, Allergy/Immunology and Environmental Health
University of Texas
San Antonio, TX, USA


Learn More

Register

Everyone is invited and it's free to participate. Microbiome First - Pathway to Sustainable Healthcare Virtual Summit taking place May 17-19, 2022.

Select the register button that best fits you.
To watch the sessions,

Click here to go to the Schedule page,

then click the speaker names to see their session
      

Individuals

Register
      

Researchers 

Register
      

Industry

Register

schedule

Visit the Schedule Page to see details.

contact form here...

Contact us to participate and help make healthcare sustainable while improving health outcomes.

GROW YOUR
GLOBAL NETWORK

Unlock opportunities for 2021 and beyond. With two days crossing paths with senior leadership from potential partners and customers, the Forum is a place to build relationships, share your knowledge, and keep the discussion going long after the weekend is over.
NEW
FRIENDS 
PARTNERS
AND CLIENTS

5500

Media Partners

Industry Supporters

waf sustainable health logo
Learn More

Sponsored By

waf sustainable health logo
Learn More
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram